GENE ONLINE|News &
Opinion
Blog

CAR-NK Cell
Senti Bio Wins FDA RMAT Designation for SENTI-202 on 50% Response Rate in Leukemia Trial
2025-12-11
Replay And MD Anderson Launches Syena To Lead TCR-NK Cell Therapy
2023-02-15
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
CAR-T Therapy – a Boon for Cancer Treatment?
2020-04-27
Gilead, Kite, and oNKo-innate Collaborate to Advance Cancer Immunotherapy Using NK Cells
2020-04-26
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top